Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
15.97
+0.50 (3.23%)
At close: Apr 13, 2026, 4:00 PM EDT
16.05
+0.08 (0.50%)
After-hours: Apr 13, 2026, 4:22 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $866.97 million as of April 13, 2026. Its market cap has increased by 757.28% in one year.
Market Cap
866.97M
Enterprise Value
426.68M
1-Year Change
757.28%
Ranking
Category
Stock Price
$15.97
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $866.97M, a decrease of -33.26%. That is a compound annual growth rate of -7.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 838.25M | 65.51% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jade Biosciences | 882.27M |
| Cullinan Therapeutics | 880.05M |
| Fortrea Holdings | 858.33M |
| SELLAS Life Sciences Group | 854.81M |
| Theravance Biopharma | 841.91M |
| Omeros | 827.24M |
| Sana Biotechnology | 824.62M |
| Bright Minds Biosciences | 818.66M |